NVLPF (Nova Leap Health) Equity-to-Asset: 0.81 (As of Mar. 2026) — 16% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVLPF Nova Leap Health Corp NVLPF
50 GF Score
Price $0.31
GF Value $0.27
Valuation Significantly Overvalued
! 1 Warning Sign
View Full Analysis

What is Nova Leap Health Equity-to-Asset?

Nova Leap Health NVLPF 50 Equity-to-Asset is 0.81 as of Mar. 2026, which is 16% above its 10-year median of 0.70. GuruFocus rates NVLPF with a GF Score™ of 50/100 and a GF Value™ of $0.27 (Significantly Overvalued). The stock has 1 warning sign investors should review. Among 682 Healthcare Providers & Services companies, Nova Leap Health ranks better than 86.66% on this metric.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Nova Leap Health's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $19.09 Mil. Nova Leap Health's Total Assets for the quarter that ended in Mar. 2026 was $23.44 Mil. Therefore, Nova Leap Health's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.81.

The historical rank and industry rank for Nova Leap Health's Equity-to-Asset or its related term are showing as below:

NVLPF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.5   Med: 0.7   Max: 0.88
Current: 0.81

During the past 10 years, the highest Equity to Asset Ratio of Nova Leap Health was 0.88. The lowest was 0.50. And the median was 0.70.

NVLPF's Equity-to-Asset is ranked better than
86.66% of 682 companies
in the Healthcare Providers & Services industry
Industry Median: 0.485 vs NVLPF: 0.81

Nova Leap Health  (OTCPK:NVLPF) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


Nova Leap Health Equity-to-Asset Related Terms


Nova Leap Health Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Nova Leap Health's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nova Leap Health Equity-to-Asset Chart

Nova Leap Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.78 0.87 0.82 0.81

Nova Leap Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.79 0.79 0.80 0.81 0.81

NVLPF vs HCA, THC, DVA: Equity-to-Asset Comparison

For the Medical Care Facilities subindustry, Nova Leap Health's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Leap Health Equity-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Nova Leap Health's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Nova Leap Health's Equity-to-Asset falls into.


NVLPF
50GF Score
Nova Leap Health Corp NVLPF
Equity-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nova Leap Health Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Nova Leap Health's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Equity to Asset (A: Dec. 2025 )=Total Stockholders Equity/Total Assets
=19.042/23.481
=0.81

Nova Leap Health's Equity to Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

Equity to Asset (Q: Mar. 2026 )=Total Stockholders Equity/Total Assets
=19.085/23.437
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of 0.81 mean?
Nova Leap Health (NVLPF) has a Equity-to-Asset of 0.81 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Nova Leap Health and its competitors. This is 16% above median its historical median of 0.70. Over the past decade, Nova Leap Health's Equity-to-Asset has ranged from 0.50 to 0.88. According to the industry distribution chart, Nova Leap Health ranks #91 out of 682 companies in the Healthcare Providers & Services industry, placing it in the top 13.3%.
Is Nova Leap Health's Equity-to-Asset too high?
Nova Leap Health's current Equity-to-Asset of 0.81 is 16% above median its 10-year median of 0.70. Over the past 10 years, this metric has ranged from a low of 0.50 to a high of 0.88. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. Nova Leap Health's value of 0.81 is 67% above this industry median. Based on the distribution chart, Nova Leap Health ranks #91 out of 682 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Nova Leap Health has a GF Score™ of 50/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Nova Leap Health's Equity-to-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Nova Leap Health ranks #91 out of 682 companies for Equity-to-Asset. This places Nova Leap Health in the top 13% of its industry — outperforming the majority of peers. The industry median Equity-to-Asset is 0.49. Nova Leap Health's value of 0.81 is 67% above this benchmark. Historically, Nova Leap Health's own Equity-to-Asset has ranged from 0.50 to 0.88 over the past decade. While the company's 10-year median is 0.70 vs. the industry median of 0.49, Nova Leap Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 682 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nova Leap Health's current Equity-to-Asset of 0.81 is 67% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Nova Leap Health and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nova Leap Health's current Equity-to-Asset is 0.81, which is 16% above median its own 10-year median of 0.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nova Leap Health stock overvalued right now?
Based on GuruFocus' analysis, Nova Leap Health (NVLPF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.27, compared to a current price of $0.31 — trading 14.1% above its estimated fair value. The current Equity-to-Asset is 0.81, which is 16% above median its 10-year median of 0.70 and 67% above the Healthcare Providers & Services industry median of 0.49. Nova Leap Health's overall GF Score™ is 50/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Nova Leap Health (NVLPF), the current Equity-to-Asset is 0.81 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nova Leap Health (NVLPF) Overvalued in 2026?

Based on GuruFocus' analysis, Nova Leap Health stock appears to be overvalued. The current stock price of $0.31 is trading 14.1% above its estimated GF Value™ of $0.27. GuruFocus considers Nova Leap Health to be Significantly Overvalued.

Key valuation signals for NVLPF:

  • Equity-to-Asset: 0.81 (16% above median its 10-year median of 0.70)
  • GF Value™: $0.27 vs. price of $0.31 (14.1% above fair value)
  • GF Score™: 50/100 with 1 warning sign
  • Industry Position: 67% above the Healthcare Providers & Services median (#91 of 682)

No single metric tells the full story. See the NVLPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Nova Leap Health Business Description

Other Exchanges NLH:Canada
Address 7071 Bayers Road, Suite 3006, Halifax, NS, CAN, B3L 2C2
Nova Leap Health Corp operates in the healthcare industry. The company is a provider of home and home health care services to clients..The principal business activities of the company and its subsidiaries are to provide skilled and non-medical home care to clients. Its service offerings include meal preparation, housekeeping, transportation, personal care, and medication reminders. Its segments comprise Canadian and U.S. operations. The company derives a majority of its revenue from the United States.
50GF Score

Get the complete analysis for NVLPF

Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.31
Price
$0.27
GF Value